MBMustafa Başak

Mustafa Başak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mustafa Başak has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Loneliness and Mental State in Cancer

    by Medine Koç, Havva Tel, Mustafa Başak, Hatice Tel Aydın, Çağdaş Akkaya, Özge Kısaoğlu

    Aim: In many ways, the diagnosis of cancer affects the individual's mental health as well as their physical health. Cancer patients may experience a complex emotional state, loneliness, and isolation at different levels during the disease process. This study was conducted to determine the mental status and loneliness of patients diagnosed with cancer.Material and Methods: This descriptive study was conducted with 185 patients diagnosed with cancer. The research data were collected with the Brief Symptom Inventory and the University of California, Los Angeles (UCLA) Loneliness Scale. The data were analyzed using IBM SPSS Statistics 22.0. The Mann-Whitney U test, Kruskal-Wallis test, and Spearman correlation were used to analyze the data.Results: The study found a significant difference in patients' Brief Symptom Inventory (BSI) scores based on various factors such as age, marital status, education, employment, income, illness duration, treatment, hospitalization, presence of another disease, adaptation to the disease, and perception of the disease. The UCLA Loneliness Scale scores were positively correlated with BSI total scores, as well as with the somatization and depression subscale scores (p < 0.05).Conclusions: The study concluded that a significant relationship existed between loneliness and mental problems in cancer patients, and that loneliness had a negative impact on their mental status. Based on the obtained results, we recommend a holistic approach to the treatment and care of cancer patients, to maintain their mental health and reduce their loneliness.Implication for nursing practice: This study highlights the need for nurses to assess and address loneliness and psychological distress in cancer patients. Integrating psychosocial support and therapeutic communication into nursing care may help improve patients’ mental well-being and adaptation to illness.

  • Open Access

    Real-World Experience with Non-Metastatic Male Breast Cancer: A 222-Patient Multicenter Study from the Turkish Oncology Group (TOG)

    by Ülkü Yalçıntaş Arslan, Ferit Aslan, Murat Ayhan, Nadiye Akdeniz, Gözde Tahtacı, Havva Yeşil Çınkır, Mevlude İnanç, Gökşen İnanç İmamoğlu, Necati Alkış, Mustafa Başak, et al.

    Male breast cancer (MBC) is a rare disease, representing approximately 1% of all breast cancers worldwide


  • Open Access

    Evaluating the role of HER2-low versus HER2-0 status in predicting response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer

    by Alper Topal, Mustafa Başak

    Objectives: The classification of human epidermal growth factor receptor 2 (HER2)-low breast cancer has gained clinical relevance following the success of antibody-drug conjugates in this subgroup. However, its prognostic and predictive role, particularly in hormone receptor-positive (HR+) early breast cancer treated with neoadjuvant chemotherapy (NACT), remains unclear. This study aimed to evaluate the impact of HER2-low versus HER2-0 status on pathological complete response (pCR) and disease-free survival (DFS) in HR+ breast cancer patients undergoing NACT. Methods: A total of 216 HR+ and HER2-negative early breast cancer patients treated with NACT at Tokat Gaziosmanpasa University Hospital between January 2014 and January 2024 were retrospectively analyzed. HER2-low was defined as IHC 1+ or 2+ without gene amplification by FISH. pCR was assessed via the Miller-Payne grading system. Survival analyses were conducted using the Kaplan-Meier method; multivariate analyses were performed using Cox regression. Results: Of the 216 patients, 30 (13.9%) achieved pCR. There was no statistically significant difference in pCR (P=0.83) or DFS (P=0.12) between HER2-0 and HER2-low groups. However, patients with ER <10% had significantly higher pCR rates (P=0.005). Achieving pCR was associated with longer DFS (P=0.045). Conclusions: HER2-0 and HER2-low subgroups exhibited similar responses to NACT in HR+ breast cancer. Low ER expression was independently associated with higher pCR. Larger prospective studies are warranted to further define the biological and clinical implications of HER2 expression levels in early-stage HR+ breast cancer.